Clinical Trial Update: Epidemiology and Treatment of HR+/HER2- Breast Cancer in England

View source ↗

Summary

A completed clinical trial update examining epidemiology and treatment patterns for HR+/HER2- breast cancer in England.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Status: COMPLETED